Other
Active Surveillance
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Active Surveillance is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Not yet recruiting2 · 25%
Unknown status2 · 25%
Completed1 · 13%
Withdrawn1 · 13%
Recruiting1 · 13%
Active, not recruiting1 · 13%
Clinical Trials
Trial Activity
8 trials
Clinical Trial of Green Tea Catechins in Men on Active Surveillance
Active, not recruiting·HH. Lee Moffitt Cancer Center and Research Institute·Phase 2·NCT04300855·115 enrolled
Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC
Not yet recruiting·—·Phase 2·NCT06861894·164 enrolled
Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC
Unknown status·—·Phase 2·NCT06059885·60 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)